
CHEMOTHERAPY FOR HIV-ASSOCIATED NON-HODGKIN LYMPHOMA (HIV-NHL) IN COMBINATION WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IS NOT ASSOCIATED WITH EXCESSIVE TOXICITY.
Author(s) -
Lee Ratner,
David Redden,
Fayez M. Hamzeh,
A Levine,
William J. Harrington,
David T. Scadden,
Lawrence D. Kaplan,
R. F. Ambinder,
Louise B. Grochow,
Charles Flexner,
Bruce K. Tan,
Straus Dj
Publication year - 1999
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00126334-199905010-00112
Subject(s) - medicine , antiretroviral therapy , lymphoma , human immunodeficiency virus (hiv) , chemotherapy , hodgkin lymphoma , non hodgkin's lymphoma , oncology , antiretroviral agents , sida , lentivirus , immunology , viral disease , viral load